From: Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Cell | Probe, pretreatment duration | DMR readout | Labels used in clustering | Figures |
---|---|---|---|---|
HEK293 | 0.1% DMSO in buffer, 1 hr | Ligand, 10 μM | HEK-3, 9, 30 | Additional file1: Figure S1, S2 |
Opioid* | 0.1% DMSO in buffer, 1hr | Ligand, 10 μM | Buffer-3, 9, 30 | |
HEK-MOR | 10 μM ligand, 1 hr | DAMGO, 10 μM | MOR-3, 9, 30 | Additional file1: Figures S2 & S3 |
HEK-DOR | 10 μM ligand, 1 hr | DPDPE, 10 μM | DOR-3, 9, 30 | Figure5 |
HEK-KOR | 10 μM ligand, 1 hr | BRL-57532, 10 μM | KOR-3, 9, 30 | Figure6 |
SH-SY5Y | 10 μM ligand, 1 hr | DAMGO, 10 μM | 5Y-3, 9, 30 | Figure7 |
Opioid* | 100 ng/ml PTX, 20 hr | Ligand, 10 μM | PTX-3, 9, 30 | |
Opioid* | 400 ng/ml CTX, 20 hr | Ligand, 10 μM | CTX-3, 9, 30 | |
Opioid* | 10 μM forskolin, 1 hr | Ligand, 10 μM | FSK-3, 9, 30 | |
Opioid* | 10 μM U0126, 1 hr | Ligand, 10 μM | U0126-3, 9, 30 | |
Opioid* | 10 μM SB202190, 1 hr | Ligand, 10 μM | SB-3, 9, 30 | |
Opioid* | 10 μM SP600125, 1 hr | Ligand, 10 μM | SP-3, 9, 30 | |
Opioid* | 10 μM LY294002, 1 hr | Ligand, 10 μM | LY-3, 9, 30 |